Poznan University of Medical Sciences, Fredry 10, 61-701, Poznań, Poland.
Pomeranian Medical University in Szczecin, Rybacka 1, 70-204, Szczecin, Poland.
Biomed Pharmacother. 2020 Sep;129:110451. doi: 10.1016/j.biopha.2020.110451. Epub 2020 Jun 23.
Here we present the results of a bibliometric survey of peer-reviewed and pre-print papers published in the English language on issues related to COVID-19 within the first three months since a cluster of a severe acute respiratory disease of unknown etiology was officially confirmed by the Chinese Center for Disease Control and Prevention on 31 December 2019. A systematic search using PubMed/Medline and Scopus databases and preprint servers was performed. The articles were classified according to their type, subject and country of origin. Up to 31 March 2020, a total of 2062 papers published in 578 peer-reviewed journals and 1425 preprints posted mostly on medRxiv (55.4 %), were identified. The mean number of published journal papers and preprints per day in the considered period was 27 and 12, respectively, and reached a maximum of 51 and 46 per day in March, respectively. The identified articles, journal papers and preprints, mostly covered the epidemiology of COVID-19 (35.7 %), clinical aspects of infection (21.0 %), preventative measures (12.8 %), treatment options (12.5 %), diagnostics (12.2 %), mathematical modeling of disease transmission and mitigation (9.6 %), and molecular biology and pathogenesis of SARS-CoV-2 (8.7 %). The majority of the journal papers were commentaries (38.5 %), reviews (33.6 %) and original research (21.3 %), while preprints predominantly presented original results (89.8 %). Chinese scientists contributed the highest share of original research and were responsible for 32.9 % journal papers and 43.9 % preprints published in the considered period. A high number of contributions was also seen from the United States, the United Kingdom, and Italy. The benefits and potential risks of such a massive publication output are discussed. The scientific response seen during the first 3 months of the COVID-19 outbreak is a demonstration of the capabilities of modern science to react rapidly to emerging global health threats by providing and discussing the essential information for understanding the etiological factor, its spread, preventative measures, and mitigation strategies.
在这里,我们呈现了一项文献计量调查的结果,该调查针对的是 2019 年 12 月 31 日中国疾病预防控制中心正式确认不明原因严重急性呼吸道疾病集群以来的头三个月内在英语发表的与 COVID-19 相关的同行评审和预印本论文。使用 PubMed/Medline 和 Scopus 数据库和预印本服务器进行了系统搜索。根据论文的类型、主题和来源国对论文进行了分类。截至 2020 年 3 月 31 日,共在 578 种同行评审期刊上发表了 2062 篇论文,在 1425 篇预印本中发表了大部分在 medRxiv 上的论文(55.4%)。在所考虑的时期内,每天发表的期刊论文和预印本的平均数量分别为 27 篇和 12 篇,3 月份分别达到了每天 51 篇和 46 篇的最高值。所确定的文章、期刊论文和预印本主要涵盖了 COVID-19 的流行病学(35.7%)、感染的临床方面(21.0%)、预防措施(12.8%)、治疗选择(12.5%)、诊断(12.2%)、疾病传播和缓解的数学建模(9.6%)以及 SARS-CoV-2 的分子生物学和发病机制(8.7%)。大多数期刊论文为评论(38.5%)、综述(33.6%)和原始研究(21.3%),而预印本主要呈现原始结果(89.8%)。中国科学家对原始研究的贡献最高,占所考虑期间发表的期刊论文的 32.9%和预印本的 43.9%。美国、英国和意大利也做出了大量贡献。讨论了这种大量出版的好处和潜在风险。在 COVID-19 爆发的头 3 个月中,这种快速的科学反应展示了现代科学应对新兴全球健康威胁的能力,为理解病因、传播途径、预防措施和缓解策略提供了必要的信息。